245 related articles for article (PubMed ID: 30659187)
1. Lsd1 as a therapeutic target in Gfi1-activated medulloblastoma.
Lee C; Rudneva VA; Erkek S; Zapatka M; Chau LQ; Tacheva-Grigorova SK; Garancher A; Rusert JM; Aksoy O; Lea R; Mohammad HP; Wang J; Weiss WA; Grimes HL; Pfister SM; Northcott PA; Wechsler-Reya RJ
Nat Commun; 2019 Jan; 10(1):332. PubMed ID: 30659187
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of Ezh2 Upregulates Gfi1 and Drives Aggressive Myc-Driven Group 3 Medulloblastoma.
Vo BT; Li C; Morgan MA; Theurillat I; Finkelstein D; Wright S; Hyle J; Smith SMC; Fan Y; Wang YD; Wu G; Orr BA; Northcott PA; Shilatifard A; Sherr CJ; Roussel MF
Cell Rep; 2017 Mar; 18(12):2907-2917. PubMed ID: 28329683
[TBL] [Abstract][Full Text] [Related]
3. Severe Inflammatory Reactions in Mice Expressing a GFI1
Fraszczak J; Arman KM; Lacroix M; Vadnais C; Gaboury L; Möröy T
J Immunol; 2021 Sep; 207(6):1599-1615. PubMed ID: 34408010
[TBL] [Abstract][Full Text] [Related]
4. LSD1 inhibition by tranylcypromine derivatives interferes with GFI1-mediated repression of PU.1 target genes and induces differentiation in AML.
Barth J; Abou-El-Ardat K; Dalic D; Kurrle N; Maier AM; Mohr S; Schütte J; Vassen L; Greve G; Schulz-Fincke J; Schmitt M; Tosic M; Metzger E; Bug G; Khandanpour C; Wagner SA; Lübbert M; Jung M; Serve H; Schüle R; Berg T
Leukemia; 2019 Jun; 33(6):1411-1426. PubMed ID: 30679800
[TBL] [Abstract][Full Text] [Related]
5. Enhancer Activation by Pharmacologic Displacement of LSD1 from GFI1 Induces Differentiation in Acute Myeloid Leukemia.
Maiques-Diaz A; Spencer GJ; Lynch JT; Ciceri F; Williams EL; Amaral FMR; Wiseman DH; Harris WJ; Li Y; Sahoo S; Hitchin JR; Mould DP; Fairweather EE; Waszkowycz B; Jordan AM; Smith DL; Somervaille TCP
Cell Rep; 2018 Mar; 22(13):3641-3659. PubMed ID: 29590629
[TBL] [Abstract][Full Text] [Related]
6. HMG20B stabilizes association of LSD1 with GFI1 on chromatin to confer transcription repression and leukemia cell differentiation block.
Maiques-Diaz A; Nicosia L; Basma NJ; Romero-Camarero I; Camera F; Spencer GJ; Amaral FMR; Simeoni F; Wingelhofer B; Williamson AJK; Pierce A; Whetton AD; Somervaille TCP
Oncogene; 2022 Oct; 41(44):4841-4854. PubMed ID: 36171271
[TBL] [Abstract][Full Text] [Related]
7. MiR-495 is a Predictive Biomarker that Downregulates GFI1 Expression in Medulloblastoma.
Wang C; Yun Z; Zhao T; Liu X; Ma X
Cell Physiol Biochem; 2015; 36(4):1430-9. PubMed ID: 26160036
[TBL] [Abstract][Full Text] [Related]
8. Nascent transcript and single-cell RNA-seq analysis defines the mechanism of action of the LSD1 inhibitor INCB059872 in myeloid leukemia.
Johnston G; Ramsey HE; Liu Q; Wang J; Stengel KR; Sampathi S; Acharya P; Arrate M; Stubbs MC; Burn T; Savona MR; Hiebert SW
Gene; 2020 Aug; 752():144758. PubMed ID: 32422235
[TBL] [Abstract][Full Text] [Related]
9. LSD1-mediated repression of GFI1 super-enhancer plays an essential role in erythroleukemia.
Tatsumi G; Kawahara M; Yamamoto R; Hishizawa M; Kito K; Suzuki T; Takaori-Kondo A; Andoh A
Leukemia; 2020 Mar; 34(3):746-758. PubMed ID: 31676828
[TBL] [Abstract][Full Text] [Related]
10. Histone demethylase UTX/KDM6A enhances tumor immune cell recruitment, promotes differentiation and suppresses medulloblastoma.
Yi J; Shi X; Xuan Z; Wu J
Cancer Lett; 2021 Feb; 499():188-200. PubMed ID: 33253789
[TBL] [Abstract][Full Text] [Related]
11. GFI1 functions in transcriptional control and cell fate determination require SNAG domain methylation to recruit LSD1.
Velinder M; Singer J; Bareyan D; Meznarich J; Tracy CM; Fulcher JM; McClellan D; Lucente H; Franklin S; Sharma S; Engel ME
Biochem J; 2016 Oct; 473(19):3355-69. PubMed ID: 27480105
[TBL] [Abstract][Full Text] [Related]
12. Growth factor independence 1 (Gfi1) as a regulator of p53 activity and a new therapeutical target for ALL.
Khandanpour C; Möröy T
Oncotarget; 2013 Mar; 4(3):374-5. PubMed ID: 23528269
[TBL] [Abstract][Full Text] [Related]
13. SUMOylation Regulates Growth Factor Independence 1 in Transcriptional Control and Hematopoiesis.
Andrade D; Velinder M; Singer J; Maese L; Bareyan D; Nguyen H; Chandrasekharan MB; Lucente H; McClellan D; Jones D; Sharma S; Liu F; Engel ME
Mol Cell Biol; 2016 May; 36(10):1438-50. PubMed ID: 26951200
[TBL] [Abstract][Full Text] [Related]
14. Gfi1, a transcriptional repressor, inhibits the induction of the T helper type 1 programme in activated CD4 T cells.
Suzuki J; Maruyama S; Tamauchi H; Kuwahara M; Horiuchi M; Mizuki M; Ochi M; Sawasaki T; Zhu J; Yasukawa M; Yamashita M
Immunology; 2016 Apr; 147(4):476-87. PubMed ID: 26749286
[TBL] [Abstract][Full Text] [Related]
15. GFI1 proteins orchestrate the emergence of haematopoietic stem cells through recruitment of LSD1.
Thambyrajah R; Mazan M; Patel R; Moignard V; Stefanska M; Marinopoulou E; Li Y; Lancrin C; Clapes T; Möröy T; Robin C; Miller C; Cowley S; Göttgens B; Kouskoff V; Lacaud G
Nat Cell Biol; 2016 Jan; 18(1):21-32. PubMed ID: 26619147
[TBL] [Abstract][Full Text] [Related]
16. LSD1 promotes S-phase entry and tumorigenesis via chromatin co-occupation with E2F1 and selective H3K9 demethylation.
He Y; Zhao Y; Wang L; Bohrer LR; Pan Y; Wang L; Huang H
Oncogene; 2018 Jan; 37(4):534-543. PubMed ID: 28991226
[TBL] [Abstract][Full Text] [Related]
17. LSD1 promotes the egress of hematopoietic stem and progenitor cells into the bloodstream during the endothelial-to-hematopoietic transition.
Tamaoki J; Maeda H; Kobayashi I; Takeuchi M; Ohashi K; Gore A; Bonkhofer F; Patient R; Weinstein BM; Kobayashi M
Dev Biol; 2023 Sep; 501():92-103. PubMed ID: 37353106
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological inhibition of LSD1 activity blocks REST-dependent medulloblastoma cell migration.
Callegari K; Maegawa S; Bravo-Alegria J; Gopalakrishnan V
Cell Commun Signal; 2018 Sep; 16(1):60. PubMed ID: 30227871
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor and sonic Hedgehog expression in cerebellar neural progenitor cells costimulate medulloblastoma initiation and growth.
Binning MJ; Niazi T; Pedone CA; Lal B; Eberhart CG; Kim KJ; Laterra J; Fults DW
Cancer Res; 2008 Oct; 68(19):7838-45. PubMed ID: 18829539
[TBL] [Abstract][Full Text] [Related]
20. Redefining the molecular substructure of medulloblastoma.
Benmaamar R
Lancet Oncol; 2017 Sep; 18(9):e514. PubMed ID: 28757377
[No Abstract] [Full Text] [Related]
[Next] [New Search]
